Aktis Oncology, Inc. (AKTS)
NASDAQ·Healthcare·Biotechnology
$22.49
+1.48%
Mkt Cap $1.23B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$35.33
Range $31.00 – $40.00
Implied Upside
+57.1%
Consensus $35.33 vs current $22.49
NASDAQ·Healthcare·Biotechnology
$22.49
+1.48%
Mkt Cap $1.23B
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$35.33
Range $31.00 – $40.00
+57.1%
Consensus $35.33 vs current $22.49